2Heres S, Davis J, Maino K, et al. Why olanzapine beats risperidone, risperdone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head - to - head comparison studies of second - generation antipsyehoties. Am J Psyehiat ,2006,163 ( 2 ) : 185 - 194.
3Keck PE, Strawn JR, Mcelroy SL. Pharmacologic treatment consideration in co -occurring bipolar and anxiety disorders. J Chin Psychiat, 2006,67 (Suppl 1 ) :8 - 15.
4Essock SM, Covell NH, Jackson CT. Antipsychotic drugs and schizophrenia. N Engl J Med,2006,354(3) :298 -300.
6[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
7[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
8[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
9[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
10[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
